FDA Warning Letter: Maitland Labs of Central Florida
type: Action
additional type: https://schema.org/RegulationAction
start time: 2021-08-17
description: Compounding Pharmacy/Adulterated Drug Products. Issued by FDA Office of Pharmaceutical Quality Operations, Division II on 2021-08-06.
agent: FDA Office of Pharmaceutical Quality Operations, Division II
object: Maitland Labs of Central Florida
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
source organization: U.S. Food and Drug Administration
publisher: AI Analytics

PropertyValue
property ID: FDA Warning Letter ID
value: 7a2f8329d2e8e90d

AI Analytics
type: Organization